No black box warning on record for Lidocaine Hydrochloride And Dextrose

As of the latest FDA labeling reviewed, Lidocaine Hydrochloride And Dextrose (LIDOCAINE HYDROCHLORIDE AND DEXTROSE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Lidocaine Hydrochloride And Dextrose medicine page for the complete safety profile.

Other warnings & precautions

Constant monitoring with an electrocardiograph is essential to the administration of lidocaine hydrochloride intravenously. Signs of excessive depression of cardiac conductivity, such as prolongation of the PR interval, widening of the QRS interval and the appearance or aggravation of arrhythmias, should be followed by prompt cessation of the intravenous infusion of this agent. It is mandatory to

No black box warning on record for Lidocaine Hydrochloride And Dextrose

Other warnings & precautions

Constant monitoring with an electrocardiograph is essential to the administration of lidocaine hydrochloride intravenously. Signs of excessive depression of cardiac conductivity, such as prolongation of the PR interval, widening of the QRS interval and the appearance or aggravation of arrhythmias, should be followed by prompt cessation of the intravenous infusion of this agent. It is mandatory to

Lidocaine Hydrochloride And Dextrose Black Box Warning

No black box warning on record for Lidocaine Hydrochloride And Dextrose

Other warnings & precautions

Lidocaine Hydrochloride And Dextrose Black Box Warning

No black box warning on record for Lidocaine Hydrochloride And Dextrose

Other warnings & precautions